- cafead   May 22, 2024 at 10:42: PM
via Eli Lilly and Pfizer have both recently launched direct-to-consumer platforms allowing patients to bypass an in-person doctor visit or brick-and-mortar pharmacy. Their decisions suggest large pharmaceutical companies are exploring new ways to reach patients and could indicate a growing trend.
article source
article source